Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Company Overview - Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures, and markets a wide range of orthopedic reconstructive products, including sports medicine, biologics, extremities and trauma products, spine, bone healing, craniomaxillofacial and thoracic products, dental implants, and related surgical products [11] - The company operates in over 25 countries and markets products in more than 100 countries [11] Investment Analysis - Zimmer Biomet currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B [12] - The company has a Momentum Style Score of A, with shares increasing by 10.3% over the past four weeks [12] - In the last 60 days, 10 analysts have revised their earnings estimates higher for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.16 to $8.11 per share [12] - Zimmer Biomet has an average earnings surprise of +1.8%, indicating a positive trend in earnings performance [12] - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Zimmer Biomet is recommended for investors' consideration [13]